Transcriptomics

Dataset Information

3

Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer


ABSTRACT: The transcription factor c-Myb has been well characterized as an oncogene in several human tumor types, and its expression in the hematopoietic stem/progenitor cell population is essential for proper hematopoiesis. However, the role of c-Myb in mammopoeisis and breast tumorigenesis is poorly understood, despite its high expression in the majority of breast cancer cases (60-80%). We find that c-Myb high expression in human breast tumors correlates with the luminal/ER+ phenotype and a good prognosis. RNAi knock-down of endogenous c-Myb levels in the MCF7 luminal breast tumor cell line increases tumorigenesis both in vitro and in vivo, suggesting a tumor suppressor role in luminal breast cancer. We created a mammary-derived c-Myb expression signature and found it to be highly correlated with a published mature luminal mammary cell signature and least correlated with a mammary stem/progenitor lineage gene signature. These data describe, for the first time, a tumor suppressor role for the c-Myb proto-oncogene in breast cancer that has implications for understanding luminal tumorigenesis and for guiding treatment. refXsample

ORGANISM(S): Homo sapiens  

SUBMITTER: Charles Perou   Katherine A Hoadley  Charles M Perou  Joel S Parker  Aaron R Thorner 

PROVIDER: E-GEOD-21371 | ArrayExpress | 2010-10-15

SECONDARY ACCESSION(S): GSE21371PRJNA126079

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

2010-10-15 | GSE21371 | GEO
2009-01-18 | E-GEOD-11429 | ArrayExpress
2010-07-06 | E-GEOD-14457 | ArrayExpress
2008-06-16 | E-GEOD-9343 | ArrayExpress
2013-10-29 | E-GEOD-50470 | ArrayExpress
2012-05-29 | E-GEOD-28712 | ArrayExpress
2013-09-03 | E-GEOD-41118 | ArrayExpress
2011-05-26 | E-GEOD-26411 | ArrayExpress
2011-09-21 | E-GEOD-30489 | ArrayExpress
2011-12-21 | E-GEOD-31870 | ArrayExpress